DCGI nod to Phase III trials of two-dose Zydus Covid-19 vaccine
NEW DELHI: The Drugs Controller General of India (DCGI) has permitted Zydus Cadila to conduct Phase III trials of ZyCoV-D,...
NEW DELHI: The Drugs Controller General of India (DCGI) has permitted Zydus Cadila to conduct Phase III trials of ZyCoV-D,...